Total Payments
$4,194
2024 Payments
$111.72
Companies
29
Transactions
239
Medicare Patients
13,720
Medicare Billing
$726,908
Payment Breakdown by Category
Food & Beverage$3,849 (91.8%)
Education$344.63 (8.2%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,849 | 233 | 91.8% |
| Education | $344.63 | 6 | 8.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $446.37 | 31 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $413.50 | 30 | $0 (2024) |
| Amgen Inc. | $372.55 | 23 | $0 (2020) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $342.15 | 35 | $0 (2020) |
| Boston Scientific Corporation | $338.07 | 10 | $0 (2020) |
| Astellas Pharma US Inc | $333.92 | 6 | $0 (2017) |
| E.R. Squibb & Sons, L.L.C. | $274.97 | 15 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $270.09 | 16 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $247.26 | 16 | $0 (2018) |
| AstraZeneca Pharmaceuticals LP | $172.97 | 12 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $111.72 | 3 | iRhythm Technologies, Inc. ($76.99) |
| 2023 | $135.28 | 6 | iRhythm Technologies, Inc. ($60.46) |
| 2022 | $87.94 | 5 | Janssen Pharmaceuticals, Inc ($36.68) |
| 2021 | $23.44 | 2 | AstraZeneca Pharmaceuticals LP ($12.12) |
| 2020 | $125.34 | 9 | AstraZeneca Pharmaceuticals LP ($29.41) |
| 2019 | $453.11 | 30 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) ($107.42) |
| 2018 | $1,107 | 70 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) ($170.25) |
| 2017 | $2,150 | 114 | Astellas Pharma US Inc ($333.92) |
All Payment Transactions
239 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/01/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $19.85 | General |
| Category: Cardiovascular | ||||||
| 04/30/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $14.88 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 01/31/2024 | iRhythm Technologies, Inc. | ZIO XT Patch (Device) | Food and Beverage | In-kind items and services | $76.99 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/11/2023 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $19.32 | General |
| Category: Iron Deficiency Anemia | ||||||
| 12/06/2023 | iRhythm Technologies, Inc. | ZIO XT Patch (Device) | Food and Beverage | In-kind items and services | $37.94 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/04/2023 | SANOFI-AVENTIS U.S. LLC | MULTAQ (Drug) | Food and Beverage | In-kind items and services | $25.03 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/18/2023 | iRhythm Technologies, Inc. | ZIO XT Patch (Device) | Food and Beverage | In-kind items and services | $22.52 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/28/2023 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $14.25 | General |
| Category: CARDIOVASCULAR | ||||||
| 05/26/2023 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $16.22 | General |
| Category: Cardiovascular | ||||||
| 11/23/2022 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID | Food and Beverage | In-kind items and services | $18.83 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/24/2022 | AstraZeneca Pharmaceuticals LP | BRILINTA (Drug) | Food and Beverage | In-kind items and services | $18.05 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/29/2022 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID | Food and Beverage | In-kind items and services | $14.38 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 04/27/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Education | In-kind items and services | $18.34 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 01/24/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Education | In-kind items and services | $18.34 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/09/2021 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $11.32 | General |
| Category: Cardiovascular | ||||||
| 01/22/2021 | AstraZeneca Pharmaceuticals LP | BRILINTA (Drug) | Food and Beverage | In-kind items and services | $12.12 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/19/2020 | AstraZeneca Pharmaceuticals LP | BRILINTA (Drug) | Food and Beverage | In-kind items and services | $15.51 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/09/2020 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $18.07 | General |
| Category: Cardiology | ||||||
| 11/20/2020 | AstraZeneca Pharmaceuticals LP | BRILINTA (Drug) | Food and Beverage | In-kind items and services | $13.90 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/13/2020 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $14.04 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 02/28/2020 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $11.70 | General |
| Category: Cardiovascular | ||||||
| 02/27/2020 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $11.31 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 02/18/2020 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $11.43 | General |
| Category: CARDIOVASCULAR | ||||||
| 02/05/2020 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $11.62 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 01/29/2020 | Boston Scientific Corporation | WATCHMAN (Device) | Food and Beverage | In-kind items and services | $17.76 | General |
| Category: STRUCTURAL HEART | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 21 | 2,836 | 3,250 | $498,677 | $156,678 |
| 2022 | 24 | 3,538 | 4,068 | $565,120 | $176,281 |
| 2021 | 25 | 3,714 | 4,447 | $629,999 | $211,843 |
| 2020 | 22 | 3,632 | 4,337 | $562,828 | $182,107 |
Total Patients
13,720
Total Services
16,102
Medicare Billing
$726,908
Procedure Codes
115
All Medicare Procedures & Services
115 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 499 | 507 | $84,669 | $25,984 | 30.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 234 | 304 | $70,528 | $25,855 | 36.7% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 64 | 64 | $42,628 | $13,168 | 30.9% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 177 | 213 | $37,914 | $12,934 | 34.1% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 105 | 108 | $36,396 | $10,729 | 29.5% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 84 | 85 | $39,545 | $10,062 | 25.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 115 | 148 | $34,336 | $9,801 | 28.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 74 | 74 | $26,418 | $8,380 | 31.7% |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | Office | 2023 | 35 | 69 | $10,833 | $6,099 | 56.3% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 848 | 972 | $20,412 | $5,842 | 28.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 99 | 119 | $22,015 | $5,423 | 24.6% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 27 | 105 | $7,350 | $4,926 | 67.0% |
| 93307 | Ultrasound of heart | Office | 2023 | 47 | 47 | $16,873 | $4,624 | 27.4% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Facility | 2023 | 42 | 42 | $7,854 | $2,258 | 28.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Facility | 2023 | 32 | 32 | $7,360 | $1,665 | 22.6% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 11 | 11 | $5,489 | $1,483 | 27.0% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Office | 2023 | 14 | 14 | $4,718 | $1,414 | 30.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 18 | 18 | $6,426 | $1,401 | 21.8% |
| 99221 | Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | Facility | 2023 | 16 | 16 | $3,984 | $1,012 | 25.4% |
| 93308 | Ultrasound of heart, follow-up | Facility | 2023 | 39 | 44 | $2,948 | $850.96 | 28.9% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Facility | 2023 | 40 | 40 | $2,280 | $621.41 | 27.3% |
| 93248 | Heart rhythm review and interpretation of continous external ekg over 8-15 days | Office | 2023 | 30 | 30 | $1,860 | $548.42 | 29.5% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Facility | 2023 | 42 | 42 | $1,596 | $423.93 | 26.6% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Office | 2023 | 25 | 25 | $1,425 | $394.80 | 27.7% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Office | 2023 | 28 | 28 | $1,064 | $297.52 | 28.0% |
About Christopher Karkut
Christopher Karkut is a Cardiovascular Disease healthcare provider based in Greenville, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/23/2007. The National Provider Identifier (NPI) number assigned to this provider is 1922208453.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Christopher Karkut has received a total of $4,194 in payments from pharmaceutical and medical device companies, with $111.72 received in 2024. These payments were reported across 239 transactions from 29 companies. The most common payment nature is "Food and Beverage" ($3,849).
As a Medicare-enrolled provider, Karkut has provided services to 13,720 Medicare beneficiaries, totaling 16,102 services with total Medicare billing of $726,908. Data is available for 4 years (2020–2023), covering 115 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Other Specialties Cardiovascular Disease
- Location Greenville, NC
- Active Since 07/23/2007
- Last Updated 02/10/2025
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1922208453
Products in Payments
- XARELTO (Drug) $446.37
- ENTRESTO (Drug) $398.62
- LifeVest (Device) $342.15
- ELIQUIS (Drug) $311.42
- Corlanor (Drug) $249.35
- PRADAXA (Drug) $191.38
- MULTAQ (Drug) $171.58
- BRILINTA (Drug) $157.53
- Adempas (Drug) $138.95
- ZIO XT Patch (Device) $137.45
- GENERAL - BRADY (Device) $123.91
- GENERAL - TACHY (Device) $115.96
- Ensite Cardiac Mapping System (Device) $99.97
- PRALUENT (Drug) $98.51
- Repatha (Biological) $97.29
- REMODULIN (Drug) $71.33
- ORENITRAM (Drug) $52.07
- RESONATE (Device) $50.96
- BYSTOLIC (Drug) $46.11
- BREO (Drug) $39.76
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Greenville
Dr. Paul Mahoney, Md, MD
Cardiovascular Disease — Payments: $2.0M
Cardiovascular Disease $2.0M
Peter Netzler, M.d, M.D
Cardiovascular Disease — Payments: $299,810
Cardiovascular Disease $299,810
Joseph Manfredi, Md, MD
Cardiovascular Disease — Payments: $287,712
Cardiovascular Disease $287,712
Dr. Gregory Harris, Md, Phd, MD, PHD
Cardiovascular Disease — Payments: $192,161
Cardiovascular Disease $192,161
Dr. Rajasekhar Nekkanti, Md, MD
Cardiovascular Disease — Payments: $124,359
Cardiovascular Disease $124,359
Jeffrey Senfield, Md, MD
Cardiovascular Disease — Payments: $112,019
Cardiovascular Disease $112,019